Inhibition of coronavirus MHV-A59 replication by proteinase inhibitors.
Denison
M R
MR
Department of Pediatrics, Vanderbilt University Medical School, Nashville, Tennessee 37232-2581, USA.
Kim
J C
JC
Ross
T
T
D000818:Animals; D002460:Cell Line; D015726:Giant Cells; D007700:Kinetics; D007976:Leupeptins / Q000494:pharmacology*; D051379:Mice; D006517:Murine hepatitis virus / Q000187:drug effects / Q000502:physiology*; D011480:Protease Inhibitors / Q000494:pharmacology*; D012367:RNA, Viral / Q000096:biosynthesis / Q000187:drug effects; D012324:RNA-Dependent RNA Polymerase / Q000378:metabolism; D013997:Time Factors; D014529:Uridine / Q000378:metabolism; D010948:Viral Plaque Assay; D014779:Virus Replication / Q000187:drug effects*
D007976:Leupeptins; D011480:Protease Inhibitors; D012367:RNA, Viral; D012324:RNA-Dependent RNA Polymerase; C032854:leupeptin; D014529:Uridine